Financhill
Sell
50

ARWR Quote, Financials, Valuation and Earnings

Last price:
$68.58
Seasonality move :
40.49%
Day range:
$65.40 - $71.50
52-week range:
$9.57 - $71.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.04x
P/B ratio:
19.99x
Volume:
5.1M
Avg. volume:
2.6M
1-year change:
190.55%
Market cap:
$9.3B
Revenue:
$829.4M
EPS (TTM):
-$0.07

ARWR Analysts' Consensus Rating

The 11 analysts providing 12-month price projections for Arrowhead Pharmaceuticals, Inc. shares anticipate an average target of $57.67, ranging from a low estimate of $17.00 to a high estimate of $85.00. This average target implies a growth of -15.94% compared to the current stock price of $68.60.

Consensus Price Target

$57.67

Highest Price Target

$85.00

Lowest Price Target

$17.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 7 6 7

Hold 5 4 4

Sell 0 0 0
Consensus Buy Buy Buy

ARWR Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is up 102.52% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock